NCT07593105Completed
Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes
Effect of Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes: A Randomized Crossover Study
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
Chronic iron overload represents a significant morbidity in Transfusion dependent β-thalassemia (TDT) leading to various endocrine complications including diabetes. The GLP-1 receptor agonist (GLP-1RA) Dulaglutide has recently been approved for pediatric type 2 diabetes (T2D) treatment. Objectives: to assess the effect of Dulaglutide versus conventional insulin therapy on glycemic metrics, pancreatic reserve, dyslipidemia and ferritin among children and adolescents with TDT related diabetes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 12 May 2026
- Start date
- 12 Oct 2024
- Primary completion date
- 12 Nov 2025
- Lead sponsor
- Ain Shams University
- Diseases
- Type 1 diabetes
- NCT number
- NCT07593105
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 12 Oct 2024 to the primary completion date, 12 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- coexisting autoimmune diseases affecting glycemic control (e.g., celiac, autoimmune thyroiditis)
- diseases that require dietary restriction (e.g., celiac disease, food allergy, eating disorders)
- chronic diabetes complications (e.g., gastroparesis)
- and those with other types of diabetes, e.g., type 2 diabetes mellitus (T2D),
Who the study is looking for
- Type 1 Diabetes
- Adolescents 12-18 years old
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ain Shams University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.